Radiopharm Theranostics Ltd ADR (NASDAQ:RADX)’s traded shares stood at 59760.0 during the last session. At the close of trading, the stock’s price was $3.98, to imply a decrease of -2.05% or -$0.08 in intraday trading. The RADX share’s 52-week high remains $50.82, putting it -1176.88% down since that peak but still an impressive 12.06% since price per share fell to its 52-week low of $3.50. The company has a valuation of $31.34M, with an average of 24830.0 shares in intraday trading volume over the past 10 days and average of 23.19K shares over the past 3 months.
Radiopharm Theranostics Ltd ADR (NASDAQ:RADX) trade information
After registering a -2.05% downside in the last session, Radiopharm Theranostics Ltd ADR (RADX) has traded red over the past five days. The 5-day price performance for the stock is -15.39%, and -18.84% over 30 days. Short interest in Radiopharm Theranostics Ltd ADR (NASDAQ:RADX) saw shorts transact 28526.0 shares and set a 2.12 days time to cover.
RADX Dividends
Radiopharm Theranostics Ltd ADR has its next earnings report out in August. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
